Alymsys (Intravenous)

Generic name:bevacizumab-maly (intravenous route) [ be-va-SIZ-yoo-mab-- maly ]
Drug class:VEGF/VEGFR inhibitors

Medically reviewed by Drugs.com. Last updated on Jun 6, 2022.

Commonly used brand name(s)

In the U.S.

• Alymsys

Pharmacologic Class: Bevacizumab

Uses for Alymsys

Bevacizumab-maly injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum.

Bevacizumab-maly injection is also used together with other medicines (eg, carboplatin and paclitaxel) to treat nonsquamous, non-small cell lung cancer (NSCLC) that has spread, come back, or cannot be removed by surgery. It is also used to treat a type of brain tumor called glioblastoma that keeps coming back (recurrent).

Bevacizumab-maly injection also used in combination with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body.

Bevacizumab-maly injection also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan) to treat platinum-resistant recurrent (cancer that keeps coming back) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who have received 2 previous treatments.

Bevacizumab-maly is an antineoplastic that helps the body fight cancer. It prevents the growth of certain types of blood vessels to cancer cells. This helps decrease the growth of cancer cells by starving them of the nutrients they need to grow.

This medicine is to be given only by or under the immediate supervision of your doctor.

Before using Alymsys

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of bevacizumab-maly injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bevacizumab-maly injection in the elderly. However, elderly patients are more likely to have age-related heart or blood vessel problems, which may require caution in patients receiving bevacizumab-maly injection.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this me...